Radiopharm Theranostics Limited Share Price
NASDAQ: RADX$0.99
+$0.99 (--%) Last updated on 29 Oct, 2026 | 19:22 ISTRadiopharm Theranostics Limited Stock Performance
Radiopharm Theranostics Limited Share Price Chart
$0.99$0.99
L
H
About Radiopharm Theranostics Limited
Radiopharm Theranostics Ltd is a clinical-stage radiotherapeutics company focused on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. It develops and commercializes radiopharmaceutical platforms for therapeutic and diagnostic applications in precision oncology. The Company develops targeted and scientifically validated radiopharmaceutical technologies in pre-clinical and clinical stages. It has one reportable segment, being the research, development, and commercialization of health technologies. The Company operates in Australia and the United States, with maximum revenue from the United States.
Radiopharm Theranostics Limited Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.35 | $0.99 | -35.29% |
Sep 2026 | $2.21 | $1.53 | -31.70% |
Aug 2026 | $3.01 | $2.24 | -25.58% |
Jul 2026 | $4.25 | $3.01 | -28.16% |
Jun 2026 | $4.58 | $4.19 | -8.71% |
May 2026 | $4.41 | $4.59 | -0.43% |
Apr 2026 | $4.29 | $4.61 | +9.76% |
Mar 2026 | $4.96 | $4.20 | -14.81% |
Feb 2026 | $5.29 | $4.93 | -2.18% |
Jan 2026 | $5.03 | $5.04 | -3.45% |
Dec 2025 | $4.53 | $5.22 | +14.98% |
Nov 2025 | $4.66 | $4.54 | -14.34% |